BAX Jan 2025 57.500 call
| Previous Close | 0.5700 |
| Open | 0.5700 |
| Bid | 0.0000 |
| Ask | 2.2000 |
| Strike | 57.50 |
| Expire Date | 2025-01-17 |
| Day's Range | 0.5700 - 0.5700 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 298 |
Simply Wall St.Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29
The board of Baxter International Inc. ( NYSE:BAX ) has announced that it will pay a dividend of $0.29 per share on the...
Business WireNew Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
DEERFIELD, Ill., May 29, 2024--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis (HF HD). The study, "Survival of expanded hemodialysis and high-flux hemodialysis patients in Colombia: a cohort study," was prese
ZacksReasons to Retain Baxter International (BAX) in Your Portfolio Now
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.
